Business Description
Viet Nam Pharmaceutical Corp - JSC
ISIN : VN000000DVN7
Total Employee Number:
861Description
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients. The products of the company are: Dai trang Thophuli Gold, Cao Sao Vang 10g, Olimpiq SXC 250% SL Capsules A+B, and VP-ARGININ HCL.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.43 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 1.81 | |||||
Interest Coverage | 1.36 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.34 | |||||
Beneish M-Score | -1.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.6 | |||||
3-Year EBITDA Growth Rate | 59.8 | |||||
3-Year EPS without NRI Growth Rate | 109.9 | |||||
3-Year Book Growth Rate | 13 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.2 | |||||
9-Day RSI | 33.51 | |||||
14-Day RSI | 36.77 | |||||
3-1 Month Momentum % | 1.94 | |||||
6-1 Month Momentum % | -0.47 | |||||
12-1 Month Momentum % | -11.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.34 | |||||
Quick Ratio | 0.79 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 130.38 | |||||
Days Sales Outstanding | 114.55 | |||||
Days Payable | 120.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5 | |||||
Dividend Payout Ratio | 0.35 | |||||
3-Year Dividend Growth Rate | -7.7 | |||||
Forward Dividend Yield % | 5 | |||||
5-Year Yield-on-Cost % | 5.03 | |||||
Shareholder Yield % | -1.52 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 9.65 | |||||
Operating Margin % | 2.26 | |||||
Net Margin % | 12.15 | |||||
EBITDA Margin % | 15.78 | |||||
FCF Margin % | -6.18 | |||||
OCF Margin % | -5.92 | |||||
ROE % | 19.69 | |||||
ROA % | 9.6 | |||||
ROIC % | 2.76 | |||||
3-Year ROIIC % | 5.1 | |||||
ROC (Joel Greenblatt) % | 43.95 | |||||
ROCE % | 22.73 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 6.92 | |||||
PE Ratio without NRI | 6.92 | |||||
Price-to-Owner-Earnings | 17.43 | |||||
PEG Ratio | 0.28 | |||||
PS Ratio | 0.84 | |||||
PB Ratio | 1.22 | |||||
Price-to-Tangible-Book | 1.26 | |||||
EV-to-EBIT | 6.9 | |||||
EV-to-EBITDA | 6.68 | |||||
EV-to-Revenue | 1.05 | |||||
EV-to-FCF | -17.2 | |||||
Price-to-GF-Value | 0.91 | |||||
Price-to-Projected-FCF | 2.02 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.3 | |||||
Price-to-Graham-Number | 0.62 | |||||
| Price-to-Net-Current-Asset-Value | 5.51 | |||||
Earnings Yield (Greenblatt) % | 14.5 | |||||
FCF Yield % | -7.37 | |||||
Forward Rate of Return (Yacktman) % | 18.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Viet Nam Pharmaceutical Corp - JSC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚«) | 5,654,456.193 | ||
| EPS (TTM) (â‚«) | 2891.109 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.09 | ||
| 3-Year Sortino Ratio | 0.14 | ||
| Volatility % | 16.45 | ||
| 14-Day RSI | 36.77 | ||
| 14-Day ATR (â‚«) | 302.50668 | ||
| 20-Day SMA (â‚«) | 20425 | ||
| 12-1 Month Momentum % | -11.02 | ||
| 52-Week Range (â‚«) | 18700 - 25900 | ||
| Shares Outstanding (Mil) | 237 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Viet Nam Pharmaceutical Corp - JSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Viet Nam Pharmaceutical Corp - JSC Stock Events
| Event | Date | Price (â‚«) | ||
|---|---|---|---|---|
| VND 1000.000000 Cash Dividend | 2025-09-04 | 22,600.00 (+0.00%) | ||
| VND 700.000000 Cash Dividend | 2024-08-29 | 26,500.00 (-0.38%) |
Show
Entries
Viet Nam Pharmaceutical Corp - JSC Frequently Asked Questions
What is Viet Nam Pharmaceutical Corp - JSC(HSTC:DVN)'s stock price today?
The current price of HSTC:DVN is â‚«20000.00. The 52 week high of HSTC:DVN is â‚«25900.00 and 52 week low is â‚«18700.00.
When is next earnings date of Viet Nam Pharmaceutical Corp - JSC(HSTC:DVN)?
The next earnings date of Viet Nam Pharmaceutical Corp - JSC(HSTC:DVN) is .
Does Viet Nam Pharmaceutical Corp - JSC(HSTC:DVN) pay dividends? If so, how much?
The Dividend Yield %  of Viet Nam Pharmaceutical Corp - JSC(HSTC:DVN) is 5% (As of Today), Highest Dividend Payout Ratio of Viet Nam Pharmaceutical Corp - JSC(HSTC:DVN) was 4.05. The lowest was 0.35. And the median was 0.48. The  Forward Dividend Yield % of Viet Nam Pharmaceutical Corp - JSC(HSTC:DVN) is 5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Viet Nam Pharmaceutical Corp - JSC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers